In vitro Activity of Repurposed Nitroxoline Against Clinically Isolated Mycobacteria Including Multidrug-Resistant Mycobacterium tuberculosis

Antimicrobial treatment options for mycobacterial infections are limited due to intrinsic resistance and the emergence of acquired resistance in Mycobacterium tuberculosis. Isolates resisting first- and second line drugs are raising concerns about untreatable infections and make the development of n...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Ada Marie, Wolke, Martina, Rybniker, Jan, Plum, Georg, Fuchs, Frieder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198898/
https://www.ncbi.nlm.nih.gov/pubmed/35721137
http://dx.doi.org/10.3389/fphar.2022.906097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198898/
https://www.ncbi.nlm.nih.gov/pubmed/35721137
http://dx.doi.org/10.3389/fphar.2022.906097

Ejemplares similares